Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Rockwell Medical (RMTI) Gross Margin (2016 - 2025)

Historic Gross Margin for Rockwell Medical (RMTI) over the last 17 years, with Q3 2025 value amounting to 14.27%.

  • Rockwell Medical's Gross Margin fell 77700.0% to 14.27% in Q3 2025 from the same period last year, while for Sep 2025 it was 15.15%, marking a year-over-year decrease of 17600.0%. This contributed to the annual value of 17.23% for FY2024, which is 68200.0% up from last year.
  • As of Q3 2025, Rockwell Medical's Gross Margin stood at 14.27%, which was down 77700.0% from 15.57% recorded in Q2 2025.
  • In the past 5 years, Rockwell Medical's Gross Margin ranged from a high of 22.03% in Q3 2024 and a low of 14.55% during Q4 2021
  • Over the past 5 years, Rockwell Medical's median Gross Margin value was 12.12% (recorded in 2022), while the average stood at 8.42%.
  • As far as peak fluctuations go, Rockwell Medical's Gross Margin plummeted by -170900bps in 2021, and later soared by 266700bps in 2022.
  • Over the past 5 years, Rockwell Medical's Gross Margin (Quarter) stood at 14.55% in 2021, then skyrocketed by 183bps to 12.12% in 2022, then increased by 7bps to 12.99% in 2023, then increased by 13bps to 14.72% in 2024, then decreased by -3bps to 14.27% in 2025.
  • Its last three reported values are 14.27% in Q3 2025, 15.57% for Q2 2025, and 16.08% during Q1 2025.